405911-26-4

Basic information

• Product Name: methyl 2-{3-[3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}-(2,2-diphenylethyl)-amino)-propoxy]phenyl}acetate
• Synonyms: methyl 2-{3-[3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}-(2,2-diphenylethyl)-amino)-propoxy]phenyl}acetate
• CAS NO: 405911-26-4
• Molecular Weight: 596.089
• Mol File: 405911-26-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: methyl 2-{3-[3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}-(2,2-diphenylethyl)-amino)-propoxy]phenyl}acetate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-{3-[3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}-(2,2-diphenylethyl)-amino)-propoxy]phenyl}acetate(405911-26-4)
• EPA Substance Registry System: methyl 2-{3-[3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}-(2,2-diphenylethyl)-amino)-propoxy]phenyl}acetate(405911-26-4)

Safety Data

• Hazardous Substances Data: 405911-26-4(Hazardous Substances Data)

Upstream product

• 612499-61-3 (3-bromopropyl)({ [2-chloro-3-(trifluoromethyl)phenyl]methyl})(2,2-diphenylethyl)amine 
• 42058-59-3 3-hydroxy-benzeneacetic acid, methyl ester 
• 405911-35-5 N-(2,2-diphenylethyl)-N-(2-chloro-trifluoromethylbenzyl)amine 
• 93118-03-7 2-chloro-3-trifluoromethylbenzaldehyde 
• 3963-62-0 2,2-Diphenylethylamine 
• 228579-12-2 methyl [3-(3-bromopropoxy)phenyl]acetate 
• 67-56-1 methanol 
• 405911-09-3 3-[3-[[[2-chloro-3-(trifluoromethyl)phenyl]methyl](2,2-diphenylethyl)amino]propoxy]benzeneacetic acid 

Downstream Products

• 1193686-65-5 C₃₅H₃₅ClF₃NO₃ 
• 1193686-64-4 C₃₆H₃₇ClF₃NO₃ 

Relevant articles and documents

LXR AGONISTS AND USES THEREOF

This invention features compounds that modulate the activity of liver X receptors, pharmaceutical compositions including the compounds of the invention, and methods of utilizing those compositions for modulating the activity of liver X receptors in the treatment of cancer.

AMIDE COMPOUNDS AND METHODS OF USING THE SAME

Disclosed is a compound having the formula (I) pharmaceutically acceptable salts or solvates thereof and pharmaceutical compositions containing the same, wherein the structural variables are as defined herein. The compounds, salts and solvates of this invention are useful as LXR agonists.

ACID AND ESTER COMPOUNDS AND METHODS OF USING THE SAME

Disclosed is a compound of having the formula (II-A), pharmaceutically acceptable salts or solvates thereof and pharmaceutical compositions containing the same, wherein the structural variables are as defined herein. The compounds, salts and solvates of this invention are useful as LXR agonists.